| Authors: |
Maddi S; Division of Infection, Immunity and Respiratory Medicine, Medicines Evaluation Unit, University Hospital of South Manchester Foundation Trust, University of Manchester., Kolsum U; Division of Infection, Immunity and Respiratory Medicine, Medicines Evaluation Unit, University Hospital of South Manchester Foundation Trust, University of Manchester., Jackson S; Division of Infection, Immunity and Respiratory Medicine, Medicines Evaluation Unit, University Hospital of South Manchester Foundation Trust, University of Manchester., Barraclough R; Department of Respiratory Medicine, University Hospital of South Manchester Foundation Trust, Manchester., Maschera B; Refractory Respiratory Inflammation DPU, GlaxoSmithKline Medicines Research Centre, Stevenage, Hertfordshire, UK., Simpson KD; Refractory Respiratory Inflammation DPU, GlaxoSmithKline Medicines Research Centre, Stevenage, Hertfordshire, UK., Pascal TG; Clinical Laboratory Sciences, GlaxoSmithKline Vaccines, Wavre, Belgium., Durviaux S; Clinical Laboratory Sciences, GlaxoSmithKline Vaccines, Wavre, Belgium., Hessel EM; Refractory Respiratory Inflammation DPU, GlaxoSmithKline Medicines Research Centre, Stevenage, Hertfordshire, UK., Singh D; Division of Infection, Immunity and Respiratory Medicine, Medicines Evaluation Unit, University Hospital of South Manchester Foundation Trust, University of Manchester. |
